Darifenacin Hydrobromide Patent Expiration
Darifenacin Hydrobromide is Used for treating a disease of altered motility or tone of smooth muscle and urinary incontinence. It was first introduced by Abbvie Inc
Darifenacin Hydrobromide Patents
Given below is the list of patents protecting Darifenacin Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Enablex | US6106864 | Pharmaceutical formulations containing darifenacin |
Aug 21, 2016
(Expired) | Abbvie |
| Enablex | US5096890 | Pyrrolidine derivatives |
Mar 13, 2015
(Expired) | Abbvie |
Darifenacin Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Darifenacin Hydrobromide Generic API Manufacturers
Several generic applications have been filed for Darifenacin Hydrobromide. The first generic version for Darifenacin Hydrobromide was by Endo Operations Ltd and was approved on Mar 13, 2015. And the latest generic version is by Polygen Pharmaceuticals Inc and was approved on Jan 6, 2020.
Given below is the list of companies who have filed for Darifenacin Hydrobromide generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2017 |
| EQ 15MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2017 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 19, 2016 |
| EQ 15MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 19, 2016 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
3. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 1, 2016 |
| EQ 15MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 1, 2016 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
4. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 13, 2015 |
| EQ 15MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 13, 2015 |
5. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 12, 2016 |
| EQ 15MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 12, 2016 |
Manufacturing Plant Locations New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. All of these versions come by the name DARIFENACIN. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jul 28, 2017 |
| EQ 15MG BASE
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Jul 28, 2017 |
7. POLYGEN PHARMS
Polygen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Polygen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Jan 6, 2020 |
| EQ 15MG BASE | tablet, extended release | Prescription | ORAL | AB | Jan 6, 2020 |
8. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 15MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 17, 2016 |
| EQ 7.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 17, 2016 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
9. XIROMED
Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the details of the strengths of this generic introduced by Xiromed.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 15MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 22, 2019 |
| EQ 7.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 22, 2019 |
Manufacturing Plant Locations New
Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||